1. Home
  2. COEP vs NDLS Comparison

COEP vs NDLS Comparison

Compare COEP & NDLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COEP
  • NDLS
  • Stock Information
  • Founded
  • COEP 2017
  • NDLS 1995
  • Country
  • COEP United States
  • NDLS United States
  • Employees
  • COEP N/A
  • NDLS N/A
  • Industry
  • COEP Biotechnology: Biological Products (No Diagnostic Substances)
  • NDLS Restaurants
  • Sector
  • COEP Health Care
  • NDLS Consumer Discretionary
  • Exchange
  • COEP Nasdaq
  • NDLS Nasdaq
  • Market Cap
  • COEP 72.1M
  • NDLS 29.8M
  • IPO Year
  • COEP N/A
  • NDLS 2013
  • Fundamental
  • Price
  • COEP $15.22
  • NDLS $0.65
  • Analyst Decision
  • COEP
  • NDLS Buy
  • Analyst Count
  • COEP 0
  • NDLS 2
  • Target Price
  • COEP N/A
  • NDLS $3.00
  • AVG Volume (30 Days)
  • COEP 37.4K
  • NDLS 2.1M
  • Earning Date
  • COEP 11-10-2025
  • NDLS 11-05-2025
  • Dividend Yield
  • COEP N/A
  • NDLS N/A
  • EPS Growth
  • COEP N/A
  • NDLS N/A
  • EPS
  • COEP N/A
  • NDLS N/A
  • Revenue
  • COEP $263,555.00
  • NDLS $494,752,000.00
  • Revenue This Year
  • COEP N/A
  • NDLS $1.19
  • Revenue Next Year
  • COEP N/A
  • NDLS N/A
  • P/E Ratio
  • COEP N/A
  • NDLS N/A
  • Revenue Growth
  • COEP N/A
  • NDLS N/A
  • 52 Week Low
  • COEP $2.31
  • NDLS $0.55
  • 52 Week High
  • COEP $19.19
  • NDLS $1.74
  • Technical
  • Relative Strength Index (RSI)
  • COEP 50.18
  • NDLS 46.01
  • Support Level
  • COEP $14.50
  • NDLS $0.67
  • Resistance Level
  • COEP $15.41
  • NDLS $0.82
  • Average True Range (ATR)
  • COEP 0.77
  • NDLS 0.12
  • MACD
  • COEP -0.11
  • NDLS -0.00
  • Stochastic Oscillator
  • COEP 37.02
  • NDLS 7.76

About COEP Coeptis Therapeutics Holdings Inc.

Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.

About NDLS Noodles & Company

Noodles & Co is a restaurant concept offering lunch and dinner within the fast-casual segment of the restaurant industry. The company's menu includes a variety of cooked-to-order dishes, including noodles and pasta, soups, salads and appetizers. The company also provides dining, pick-up and delivery services.

Share on Social Networks: